Unlike other gastrointestinal adenocarcinomas, including sporadic colorectal and pancreatic adenocarcinomas, human GE adenocarcinomas develop TP53 mutations early in neoplasia, often found in premalignant lesions [10,11]. This evidence concerns the gene TP53 and pancreatic adenocarcinoma.